PATENT CLAIM ANALYSIS

Application Number: 16107689
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "158000"]

Abstract:
Provided herein (among other things) are protease inhibitor compounds having enhanced features, along with methods for administering such compounds. For example, the subject compounds can be administered without concomitant administration of a CYP3A4 inhibitor, have increased therapeutic index and/or increased potency, and are low-resistance inducing in nature.

Claim (Index 16):
A protease inhibitor conjugate having a structure as set forth in any one of  claims 9 - 15 , wherein the potency of the protease inhibitor covalently attached to the water-soluble oligomer has a greater potency than the small drug molecule in unconjugated form.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 96.0
- Lexical Diversity: 1.19565
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15228793', '12530363', '14055581', '13933319', '13411089']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7676654924416297
- 35 USC 102 Novelty (BERT): 0.6203878662147907
- Combined Prediction Score: 0.7529377298189459
- Mean Citation Score: 321.917588
- Max Citation Score: 658.2316
- Similarity Product: 483.5210094528913

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test